Ken Griffin's position in Neogenomics is currently worth $1.03 Million. That's 0.00% of their equity portfolio (2752nd largest holding). The first Neogenomics trade was made in Q3 2013. Since then Ken Griffin bought shares 50 more times and sold shares on 31 occasions. The investor's estimated purchase price is $2.05 Million, resulting in a loss of 50%.